CIK 0001631574
- Large accelerated filer
Wave Life Sciences, Inc.
Sign in to watch- Ticker
- WVE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-949-2900
- Business address
- 733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
- Former names
- Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
- 4 Grant or award Chief Commerical Officer acquired 39,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Medical Officer sold 3,058 shares at an average $26.94 ($82,368)
- 4 Open-market sale President and CEO sold 50,000 shares at an average $45.48 ($2,273,804)
- 4 Grant or award Chief Financial Officer acquired 13,500 shares (grant or award)
- 4 Open-market sale Franchise Lead, Neurology sold 7,000 shares at $48.00 ($336,000)
- 4 Grant or award President and CEO acquired 60,000 shares (grant or award)
- 4 Grant or award Francis Chris acquired 13,500 shares (grant or award)
- 4 Grant or award Senior VP, Drug Discovery acquired 15,000 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 1,298 shares at $36.84 ($47,818)
- 4 Open-market sale Franchise Lead, Neurology sold 1,837 shares at $36.84 ($67,674)
- 4 Open-market sale President and CEO sold 7,733 shares at an average $36.40 ($281,456)
- 4 Open-market sale Senior VP, Drug Discovery sold 2,055 shares at $36.84 ($75,706)
- 4 Open-market sale Francis Chris sold 1,709 shares at $36.84 ($62,959)
- 4 Open-market buy Director bought 263,158 shares at $38.00 ($10,000,004)
- 4 Open-market sale Director sold 15,000 shares at an average $38.86 ($582,849)
- 4 Open-market sale Francis Chris sold 11,575 shares at $56.00 ($648,200)
- 4 Open-market sale Chief Financial Officer sold 29,500 shares at $55.00 ($1,622,500)
- 4 Open-market sale Senior VP, Drug Discovery sold 3,000 shares at $55.00 ($165,000)
- 4 Derivatives Options or other derivatives
Page 10 of 14 · 274 filings